BODY - The Beachbody Company, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
760,299
692,199
873,645
863,582
755,779
Cost of revenue
377,789
322,626
328,662
249,707
210,319
Gross profit
382,510
369,573
544,983
613,875
545,460
Operating expenses
Research development
119,713
104,363
119,915
93,036
84,132
Selling general and administrative
476,019
438,413
627,812
528,818
441,275
Total operating expenses
595,732
542,776
747,727
621,854
525,407
Operating income or loss
-213,222
-173,203
-202,744
-7,979
20,053
Interest expense
1,220
3,368
536
527
790
Total other income/expenses net
-85,115
-20,674
-40,641
2,343
-358
Income before tax
-299,557
-197,245
-243,921
-6,163
18,905
Income tax expense
-4,336
-3,053
-15,539
15,269
-13,390
Income from continuing operations
-295,221
-194,192
-228,382
-21,432
32,295
Net income
-295,221
-194,192
-228,382
-21,432
32,295
Net income available to common shareholders
-295,221
-194,192
-228,382
-21,432
32,295
Basic EPS
-
-0.63
-0.83
-0.07
0.11
Diluted EPS
-
-0.63
-0.83
-0.07
0.11
Basic average shares
-
307,489
275,359
304,427
304,427
Diluted average shares
-
307,489
275,359
304,427
304,427
EBITDA
-
-119,029
-183,788
38,621
64,354